New-onset atrial fibrillation in sepsis is associated with increased ...
Recommend Documents
Jun 28, 2016 - for the following gene targets: SLN, PLN, Triadin (TRDN), SERCA2A, MYH6 (Applied. Biosystems). For each .... LMS disease. 25%. 33%. 0.626.
Sep 14, 2016 - ... would like to gratefully acknowledge Mr. Michael Bassett-Smith, Mr. Peter Glee- ... Raposeiras-Roubin S, Rodino-Janeiro BK, Grigorian-Shamagian L, ... Fukuda K, Shen W. Decreased endogenous secretory RAGE and.
analysed by immunostaining and Masson's trichrome, respectively. We found raised .... filtration within myocardial tissues, a Masson's trichrome staining was.
illustrated in the SAFE study201 in which targeted opportunistic screening ..... calculated using the GRADEpro software,
Sep 5, 2013 - Stoke has been reported to have a high rank in cause of death in .... Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent.
stratification in patients with atrial fibrillation has been almost exclusively restricted to ..... (3) Pectinate muscles should not be confused with pathology.
In case of an emergency - Call 911! 31. 10. Go AS, Hylek EM, Phillips ... August 2010. http://www.aarp.org/relationships
Thammasat University (Rangsit Campus). Pathumthani, Thailand [email protected]. Tachapong Ngarmukos. Faculty of Medicine Ramathibodi Hospital,.
Dronedarone is a recently developed new class. III antiarrhythmic drug which possesses elec- trophysiological properties of all four Vaughan-. Williams classes.
Jun 27, 2018 - and Nutrition, the Ohio State Wexner Medical Center, 95 West. 12th Avenue ... database (NRD) was performed during the calendar year. 2013.
Feb 10, 2011 - with the use of chi-square tests. Results. Patients ... 5599 patients enrolled in the study (43%), the physician had ... tion), there were 45 major bleeding events (1.4% per year) ...... Pineo G, Chen D, Portman RJ. Apixaban.
New-onset atrial fibrillation in sepsis is associated with increased ...
Abstract Background The development of new-onset atrial fibrillation in sepsis has been associated with adverse outcomes. Methods A systematic literature search was conducted to retrieve articles that investigated the association of new-onset atrial fibrillation in patients diagnosed with sepsis. The primary outcome of interest was the pooled risk ratio (RR) of in-hospital mortality in patients with new-onset atrial fibrillation and sepsis. Results Six studies included 3100 patients with new-onset atrial fibrillation in sepsis and 36,900 patients without newonset atrial fibrillation in sepsis. The pooled RR for in-hospital mortality was 1.45 (95 % CI 1.32–1.60, p
